Skip to content
Screener

LifeMD, Inc. LFMD Q1 2025 earnings

Reported May 6, 2025 · After market close

Revenue$65.7MBeat by $233.1K
EPS$0.01Beat by $0.05
Revenue estimate$65.5M
EPS estimate-$0.04

Next report

Nov 11, 2026 (in 2 months)
Revenue estimate$48.9M
EPS estimate-$0.14

Financials

Q1 2025

Income statement

See full
Revenue$50.9M+15.3%
Gross profit$42.8M+8.1%
Operating income-$1.2M+80.9%
Net income-$183.8K+97.3%
EPS (diluted)-$0.02+89.5%

Balance sheet

See full
Cash & equivalents$32.0M+21.0%
Total debt$26.7M+265%
Total equity-$2.3M-175%
Total assets$73.6M+19.8%

Cash flow

See full
Operating cash flow$3.1M-41.0%
CapEx$117.5K-33.1%
Free cash flow$3.0M-41.3%

Valuation & ratios

Valuation

as of 03/31/25
See full
Market cap$242.54M-35.7%
Enterprise value$237.26M-33.8%
P/S1.5×-0.8×

Profitability

See full
Gross margin85.2%-3.0pp
Operating margin-10.9%0.0pp
Net margin-10.4%-2.2pp
FCF margin8.7%-1.2pp

Returns & leverage

See full
Current ratio0.8×-0.2×

Segments

By segment

See full
Telehealth$50.9M+65.0%
Telehealth Subscription Revenue$30.1M—

FAQ

When did LifeMD, Inc. report Q1 2025 earnings?
LifeMD, Inc. (LFMD) reported Q1 2025 earnings on May 6, 2025 after market close.
What were LifeMD, Inc.'s Q1 2025 revenue and EPS?
LifeMD, Inc. reported revenue of $65.7M and eps of $0.01 for Q1 2025.
Did LifeMD, Inc. beat estimates in Q1 2025?
Revenue beat the consensus estimate of $65.5M by $233.1K. EPS beat the consensus estimate of $-0.04 by $0.05.
How did LifeMD, Inc.'s Q1 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 48.8% from $44.1M a year earlier.
Where can I find LifeMD, Inc.'s Q1 2025 SEC filings?
You can read the 8-K earnings release (0001641172-25-008841) and the 10-Q periodic report (0001641172-25-008864) directly on SEC EDGAR. The filing index links above go to sec.gov.